BridgeMD
New treatment option for Peripheral Artery Disease
Official title Radiotracer-Based Perfusion Imaging of Patients With Peripheral Arterial Disease
ClinicalTrials.gov ID: NCT03622359
What this study is testing
- What it's testing
- The aim of this clinical study is to 1) establish a healthy database for nuclear perfusion imaging of the lower extremities and 2) assess the prognostic value of radiotracer-based perfusion imaging for predicting clinical outcomes in patients with peripheral artery disease (PAD) who are undergoing lower extremity revascularization procedures. We hypothesize that radiotracer imaging of the lower extremities will provide a sensitive non-invasive imaging tool for quantifying regional abnormalities in skeletal muscle perfusion and evaluating responses to medical treatment.
- Time commitment: about 12 months
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older. Healthy volunteers may be eligible.
You may be able to join if
- for Patients with Peripheral Artery Disease:
- At least 18 years of age
- Evidence of significant obstructive disease for one or multiple lower extremity arteries, as identified by prior ABI, TBI, CT angiography...
You likely can't join if
- for Patients with Peripheral Artery Disease:
- Unable to give informed consent or follow-up
- Pregnant or nursing
- Under the age of 18
- No history of peripheral artery disease Inclusion Criteria for Healthy Control people:
- At least 18 years of age
See the full eligibility criteria
- for Patients with Peripheral Artery Disease:
- At least 18 years of age
- Evidence of significant obstructive disease for one or multiple lower extremity arteries, as identified by prior ABI, TBI, CT angiography, ultrasound, or MR imaging.
- for Patients with Peripheral Artery Disease:
- Unable to give informed consent or follow-up
- Pregnant or nursing
- Under the age of 18
- No history of peripheral artery disease Inclusion Criteria for Healthy Control people:
- At least 18 years of age
- No evidence or prior diagnosis of peripheral artery disease based on chart review and standard vascular screening. Exclusion Criteria for Healthy Control people:
- Unable to give informed consent of follow-up
- Pregnant or nursing
- Under the age of 18
- History of peripheral artery disease
The study team makes the final eligibility decision.
Where it's taking place
- Columbus, Ohio, United States
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The study runs about 12 months per participant, based on its public description. The team confirms the exact schedule and number of visits before you enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. Healthy volunteers may be eligible. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Columbus, Ohio, United States. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.